Moderna Announces New Supply Agreement for 2023 with Switzerland for Additional Seven Million Doses of Moderna’s COVID-19 Booster Vaccine

3 years ago

CAMBRIDGE, MA / ACCESSWIRE / March 21, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics…

Athira Pharma Presents Study Overview and Baseline Data from ACT-AD Phase 2 Trial of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease at the 2022 AD/PD™ Congress

3 years ago

BOTHELL, Wash., March 20, 2022 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on…

Core One Labs to Investigate Soliciting Investment and Potential Takeover Opportunities

3 years ago

VANCOUVER, British Columbia, March 19, 2022 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN:…

Advanced Proteome Therapeutics Announces Warrant Extension

3 years ago

Vancouver, British Columbia--(Newsfile Corp. - March 18, 2022) - Advanced Proteome Therapeutics Corporation (TSXV: APC) (FSE: 0E81) ("APC" or the "Company") announces that,…

Cloud DX Announces Closing of Private Placement

3 years ago

KITCHENER, ON / ACCESSWIRE / March 18, 2022 / Cloud DX (TSXV:CDX)(OTCQB:CDXFF), a leading North American provider of virtual care…

All of Us Research Program Releases Genomic Data to Researchers, Combined with Participant-Generated Data Collected on Vibrent Health’s Digital Health Research Platform

3 years ago

Precision medicine initiative leverages innovative technologies and unprecedented 80% diverse participant base to drive new research aiming to support novel…

Melzi Surgical to Present at the LSI USA ’22 Emerging Medtech Summit

3 years ago

Presentation on Friday, March 18th at 2:00 PM PTRENO, NV / ACCESSWIRE / March 18, 2022 / Melzi Surgical ("Melzi"…

Welcome to IRLAB’s Capital Markets Day 2022

3 years ago

GOTHENBURG, SWEDEN / ACCESSWIRE / March 18, 2022 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA)IRLAB (Nasdaq Stockholm: IRLAB A) will host a capital…

Shineco, Inc. Plans to Introduce a Private Equity Fund to Help its Business Transition

3 years ago

BEIJING, March 18, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of…

Optimi Health Begins Cultivation Of Natural Psilocybin For Use In Clinical Trials

3 years ago

VANCOUVER, British Columbia, March 18, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or…